US limits Covid-19 boosters to over-65s or those at high risk
The FDA said it would rely on lab test results to approve boosters for people who are over 65, or over six months old with at least one underlying condition. PHOTO: REUTERS
US limits Covid-19 boosters to over-65s or those at high risk
WASHINGTON - The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine makers to run fresh clinical trials before offering shots to younger and healthier individuals, officials said on May 20.
Writing in the New England Journal of Medicine, the Food and Drug Administration's Dr Vinayak Prasad and Commissioner Martin Makary framed the policy shift as 'evidence-based' and would align the United States more closely with guidance in Europe.
But it comes as Health Secretary Robert F. Kennedy Jr, a longtime vaccine sceptic, pushes to remake federal public health policy.
Mr Kennedy previously led a non-profit that was critical of immunisation programs, and during the pandemic petitioned the FDA to revoke Covid-19 vaccine authorisations, citing rare side effects including heart inflammation.
Dr Prasad and Mr Makary praised the initial Covid-19 vaccine rollout as 'a major scientific, medical, and regulatory accomplishment,' but argued that the benefits of repeated boosters for low-risk individuals are uncertain.
They criticised the US approach of recommending boosters for all adults regardless of age or health status, calling it a 'one-size-fits-all' model based on the mistaken belief that Americans couldn't handle more nuanced, risk-based advice.
Rather than building public trust, they wrote, it had backfired – fuelling vaccine hesitancy that has spilled over into scepticism toward childhood shots, including those for measles.
The FDA said it would rely on lab test results to approve boosters for people who are over 65, or over six months old with at least one underlying condition.
But for healthy individuals between six months and 64 years, regulators will now require data from randomised trials.
'We simply don't know whether a healthy 52-year-old woman with a normal BMI (body mass index) who has had Covid-19 three times and has received six previous doses of a Covid-19 vaccine will benefit from the seventh dose,' they wrote.
Some infectious disease experts welcomed the shift.
Dr Amesh Adalja of Johns Hopkins University said it matched with the approach taken by other countries in a population that already carries significant immunity.
'For lower-risk individuals, the goal has always been less clear, as protection against infection is transient and they don't have a high risk of severe disease,' he told AFP.
But others voiced concern about the practical consequences.
Dr Paul Offit, a leading vaccine expert at the Children's Hospital of Philadelphia, said it could limit access for people who still want boosters.
'Any use, say in a healthy 35-year-old, would be considered off-label, and you wonder whether an insurance company would pay for it,' he told AFP.
Not like annual flu shot
Under the revised framework, companies like Pfizer and Moderna will be encouraged to test updated boosters in adults aged 50 to 64.
These studies should measure whether the vaccines reduce symptomatic infections, hospitalizations and deaths.
Rather than comparing new shots to earlier formulations, Dr Prasad and Mr Makary suggested placebo-controlled trials – with saline as the comparator – to better evaluate both benefit and potential side effects.
The proposal, first floated by Mr Kennedy earlier in May, has proved divisive. Critics argue that using a placebo – when authorised vaccines already exist – could expose participants to unnecessary harm.
'Imagine if there was a death or two in the placebo group,' said Dr Offit. 'I don't see how your conscience allow that.'
Supporters of continued Covid-19 boosters often draw parallels to annual flu shots.
But Mr Makary and Dr Prasad pushed back on that comparison, arguing the genetic changes in Covid-19 variants haven't been significant enough to justify automatically updating the vaccine each year.
The FDA officials also sought to reassure Americans concerned they might lose access to boosters under the new framework.
The Centres for Disease Control and Prevention's (CDC) definition of risk factors is 'vast, including obesity and even mental health conditions such as depression,' they wrote, noting that between 100 million and 200 million Americans would likely still qualify. AFP
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
5 hours ago
- Straits Times
Tehran says at least 13 Iranians die during haj pilgrimage
Medics transport a man suffering from heat stroke to a hospital in the holy city of Mecca. PHOTO: AFP Tehran says at least 13 Iranians die during haj pilgrimage TEHRAN – At least 13 Iranians died while performing the haj pilgrimage in Saudi Arabia amid rising temperatures in the holy cities, Iranian state media reported on June 7. 'As of Friday, June 6, the total number of Iranian pilgrims who have passed away during haj 2025 has reached 13,' the health and treatment operations unit of the Iranian Red Crescent Society said in a statement carried by the official Irna news agency. 'In recent days, temperatures in the holy cities of Saudi Arabia have risen to 47 deg C, which can lead to severe heat stroke among pilgrims,' Irna said, adding that 86,700 Iranians went to Saudi Arabia in 2025 for the pilgrimage. In 2024, more than 1,300 people, including 22 Iranians, died at the haj pilgrimage in Saudi Arabia where temperatures hit 51.8 deg C. Heat stress occurs when the body's natural cooling systems are overwhelmed, causing symptoms ranging from dizziness and headaches to organ failure and death. The statement on June 7 also advised pilgrims to avoid direct sun exposure, stay hydrated and take other precautions to reduce the risk of heatstroke. Climate change is driving an increasing number of deadly heatwaves across the globe, with the World Health Organisation estimating that heat kills at least half a million people every year, warning that the real figure could be up to 30 times higher. AFP Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
17 hours ago
- Straits Times
Used in Covid-19 shots, mRNA may help rid the body of HIV
The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. PHOTO: UNSPLASH Used in Covid-19 shots, mRNA may help rid the body of HIV NEW YORK - The technology that powered Covid-19 vaccines may also lead scientists to a cure for HIV. Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely. The research, published last week in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab. But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries. Short for messenger RNA, mRNA is a set of instructions for a gene. In the case of Covid-19 vaccines, the instructions were for a piece of the coronavirus. In the new study, they are for molecules key to targeting HIV. Dr Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a 'miraculous' tool 'to deliver things that you want into places that were not possible before.' Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body's immune response. In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear. Some officials, including Health Secretary Robert F. Kennedy Jr, have falsely said that they are highly dangerous and even deadly. Last week, the Department of Health and Human Services sought to limit the vaccine's availability to pregnant women, children and healthy younger adults. The administration also cancelled a nearly US$600 million (S$773.72 million) contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu. 'The fear right now is not rational,' Dr Lewin said, adding that 'mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks.' The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors. Dr Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a 'promising, absolutely powerful technology.' Although most people may have only heard of mRNA's use in science during the pandemic, scientists have been working with it for more than 20 years, she said. 'I think it's not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,' she added. Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels. Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge. A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called 'shock and kill.' A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs. The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects. 'It's fair to say the field's been a little bit stuck,' said Dr Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research. In 2022, Dr Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.) 'You get just a little bit of a gentle nudge with some of these vaccines, and it's enough to coax some of these latent viruses out so they can be killed,' Dr Jones said. Dr Lewin and her colleagues had for years experimented with other ways to activate HIV, but had no luck in resting cells. Seeing the success of the Covid-19 vaccines, which used lipid nanoparticles – tiny spheres of fat – containing mRNA, her team tested similar particles. They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can 'edit' genes. The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy. 'It's very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,' Dr Muecksch said. It's unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce. Dr Lewin said that 'mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug.' In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives. The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials. NYTIMES Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
a day ago
- Straits Times
Norwegian gynaecologist jailed for dozens of rapes over 18 years
Norwegian gynaecologist jailed for dozens of rapes over 18 years OSLO – A Norwegian court on June 6 sentenced a doctor to 21 years in prison for committing dozens of rapes over a period of almost two decades. Arne Bye, 55, was found guilty of committing 70 counts of rape and sexual assault during gynecological examinations of his patients between 2004 and 2022. He was also condemned for 80 instances of abuse of his position. Bye committed the acts at his medical practice in the town of Frosta in central Norway. The court in the city of Trondelag barred the doctor from exercising his profession indefinitely and demanded he financially compensate his victims. Ninety-four women testified during the trial, describing how Bye committed multiple acts of non-consensual touching and digital penetration without medical justification. The acts all constitute rape under Norwegian law. Bye also filmed the assaults. 'The suspect's actions make this case an extremely serious one. The actions are unacceptable,' the Adresseavisen newspaper quoted judge Espen Haug as saying in court. The sentence matched the one requested by the prosecution. Bye's defence had argued for lesser sentence, recognising only 20 of the rapes. AFP Join ST's Telegram channel and get the latest breaking news delivered to you.
